Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 09/30/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -279.20K | -592.60K | 577.20K | 577.20K | -645.80K |
| Total Depreciation and Amortization | 24.60K | 24.20K | 21.40K | 21.40K | 21.90K |
| Total Amortization of Deferred Charges | 30.20K | 63.30K | 137.00K | 137.00K | 133.90K |
| Total Other Non-Cash Items | 36.80K | 156.80K | -1.03M | -1.03M | 137.10K |
| Change in Net Operating Assets | 800.00 | 255.50K | 133.10K | 133.10K | 68.10K |
| Cash from Operations | -186.80K | -92.80K | -165.30K | -165.30K | -284.80K |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.80K | 10.00K | 48.30K | 48.30K | -10.50K |
| Cash from Investing | -9.80K | 10.00K | 48.30K | 48.30K | -10.50K |
| Total Debt Issued | 276.90K | 203.20K | 256.80K | 256.80K | 410.50K |
| Total Debt Repaid | -80.20K | -120.40K | -150.20K | -150.20K | -111.70K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | -- |
| Cash from Financing | 196.70K | 82.80K | 106.60K | 106.60K | 298.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -10.40K | -10.40K | 3.50K |